Investing.com - Novocure Ltd reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novocure Ltd announced earnings per share of $-0.25 on revenue of $130.99. Analysts polled by Investing.com anticipated EPS of $-0.26 on revenue of $132.42M.
Novocure Ltd shares are down 4% from the beginning of the year and are trading at $67.02 , down-from-52-week-high.
Novocure Ltd shares lost 4.53% in pre-market trade the report.
Novocure Ltd follows other major Healthcare sector earnings this month
Novocure Ltd's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar